🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

FungiScope - A Global Emerging Fungal Infection Registry

Recruitingn/aAges any - anyAllUniversity of Cologne
NCT01731353 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The objective of this registry is to broaden the knowledge on epidemiology, diagnostic procedures and clinical course of emerging invasive fungal infections.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Cultural, histopathological, antigen or DNA evidence of invasive fungal infection Exclusion Criteria: * Infection due to Candida spp., Cryptococcus neoformans, Pneumocystis jiroveci * Endemic fungal infection such as coccidioidomycosis or histoplasmosis * Colonisation or other non-invasive infection
💊

What it tests

  • Not listed
📍

Where

1 site
University Hospital Cologne
Cologne, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy